Table 1. Association of baseline HIV diversity with baseline demographic, laboratory, and clinical characteristics*.
Variable | GAG1 | GAG2 | POL | ENV1 | ENV2 | ENV3 |
---|---|---|---|---|---|---|
Sex | 0.53 | 0.66 | 0.31 | 0.39 | 0.13 | 0.51 |
Age category | 0.75 | 0.87 | 1.00 | 0.53 | 0.89 | 0.46 |
Education level | 0.88 | 0.17 | 0.67 | 0.61 | 0.99 | 1.00 |
Geographical region | 0.19 | 0.28 | 0.52 | 0.78 | 0.017 | 0.50 |
CD4 (per 100 CD4 increment) | 1.00 | 0.58 | 0.39 | 0.15 | 0.38 | 0.30 |
VL (per unit log10 VL increment) | 0.74 | 0.78 | 0.52 | 0.28 | 0.51 | 0.32 |
ARV resistance | 0.19 | 0.84 | 0.39 | 0.07 | 1.00 | 0.049 |
Previous ARV for PMTCT | 0.47 | 0.10 | 0.28 | 0.33 | 0.58 | 0.58 |
Abbreviations: VL: viral load; ARV: antiretroviral; PMTCT: prevention of mother-to-child transmission.
* Univariate quantile (median) regression analysis was used for all variables. None of the p-values was considered significant after adjusting for multiple comparisons using the Benjamini-Hochberg correction.